Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 711.10
+1.70 (0.24%)
Sep 17, 2025, 10:30 AM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 35.98 billion as of September 16, 2025. Its market cap has decreased by -49.48% in one year.
Market Cap
35.98B
Enterprise Value
35.93B
Revenue
8.50B
Ranking
n/a
PE Ratio
42.22
Stock Price
711.10
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 35.98B, an increase of 4,846.75%. That is a compound annual growth rate of 122.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 35.98B | -60.74% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | 4.98B | 584.72% |
| Nov 3, 2020 | 727.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,843.73B |
| Divi's Laboratories | 1,607.94B |
| Cipla | 1,250.65B |
| Apollo Hospitals Enterprise | 1,123.89B |
| Mankind Pharma | 1,067.15B |
| Zydus Lifesciences | 1,043.36B |
| Fortis Healthcare | 738.08B |
| Alkem Laboratories | 657.67B |